Robin Shane Readnour Sells 6,100 Shares of Anthem (NASDAQ:ANTX) Stock

Anthem, Inc. (NASDAQ:ANTX) Director Robin Shane Readnour sold 6,100 shares of the company’s stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $6.07, for a total value of $37,027.00. Following the transaction, the director owned 562,715 shares of the company’s stock, valued at approximately $3,415,680.05. This represents a 1.07% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Robin Shane Readnour also recently made the following trade(s):

• On Tuesday, September 8th, Robin Shane Readnour sold 10,019 shares of Anthem stock. The stock was sold at an average price of $6.02, for a total value of $60,314.38.
• On Monday, August 17th, Robin Shane Readnour sold 35,402 shares of Anthem stock. The shares were sold at an average price of $6.01, for a total transaction of $212,766.02.

Anthem Stock Down 4.2%

NASDAQ:ANTX opened at $5.73 on Thursday. The firm’s fifty day simple moving average is $5.35 and its 200 day simple moving average is $4.44. The stock has a market cap of $216.25 million, a P/E ratio of -5.36 and a beta of -0.99. Anthem, Inc. has a twelve month low of $1.00 and a twelve month high of $7.19.

Anthem (NASDAQ:ANTX) last issued its quarterly earnings data on Tuesday, August 11th. The company reported ($0.18) EPS for the quarter.

Analysts Set New Price Targets

Several analysts have commented on the stock. Leerink Partners upgraded shares of Anthem from a “market perform” rating to an “outperform” rating and set a $9.00 price objective for the company in a report on Thursday, May 14th. Guggenheim started coverage on Anthem in a report on Monday, July 20th. They set a “buy” rating and a $9.00 target price on the stock. Wall Street Zen raised Anthem from a “sell” rating to a “hold” rating in a research report on Sunday, June 14th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Anthem in a research note on Monday, July 6th. Two investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Anthem has an average rating of “Hold” and an average price target of $9.00.

Institutional Investors Weigh In On Anthem

Several hedge funds have recently bought and sold shares of the business. Seven Fleet Capital Management LP grew its holdings in Anthem by 4.6% in the second quarter. Seven Fleet Capital Management LP now owns 208,946 shares of the company’s stock worth $1,011,000 after purchasing an additional 9,245 shares during the period. Velan Capital Investment Management LP purchased a new position in shares of Anthem during the second quarter valued at approximately $194,000. Citizens Financial Group Inc. RI bought a new stake in shares of Anthem in the 2nd quarter worth approximately $1,443,000. Vivo Capital LLC bought a new stake in shares of Anthem in the 1st quarter worth approximately $10,785,000. Finally, Bank of America Corp DE grew its stake in shares of Anthem by 2.2% in the 1st quarter. Bank of America Corp DE now owns 393,702 shares of the company’s stock worth $1,346,000 after buying an additional 8,390 shares during the last quarter. Institutional investors own 90.47% of the company’s stock.

Anthem Company Profile

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products.